Pump Yourself Thin: This Device Helps Lose Weight After Every Meal
US FDA approved US startup Aspire Bariatrics’ non surgical, endoscopic alternative for weight loss-AspireAssist Aspiration Therapy System to fight obesity in moderate to severe obese people.
A novel approach towards reducing the obesity of people has been brought forward by Aspire Bariatrics. There unusual weight loss device, AspireAssist is a minimally invasive, weight loss device which comes with a tube, a small skin-port and a small stomach pump. It performs the duty of the body’s excretory system but with a slight “twist”. This video explains the functioning of AspireAssist (Courtesy: Aspire Bariatrics).
“The AspireAssist approach helps provide effective control of calorie absorption, which is a key principle of weight management therapy,” said the FDA’s Dr. William Maisel.
The video below explains the procedure to implant AspireAssist (Courtesy: Aspire Bariatrics).
AspireAssist has been devised for the adults whose Basal Metabolic Index (BMI) is from 30 to 55 and failed to lose the weight by the traditional therapies. Using the pump for a long time along with the medical monitoring and regular counselling for diet and exercise will help the patient to get rid of their obesity.
Recently, a study was conducted on 171 volunteers in US to evaluate the efficiency of the AspireAssist therapy. Its previous study, demonstrated a weight loss of about 46 pounds during the first year which reached to almost 50 pounds in the second year.
The device may have raised some eyebrows as 30% drainage of the stomach ingredient may cause dehydration, loss of vital nutrients; it also increases the risk of infection and leakage. It was referred as “assisted bulimia” by some critics but when the device can help an extremely obese person to lose on an average 12 % or more of the body weight; it is worth using because its result was far better than the pills or normal dieting plans.
According to the Centers for Disease Control and Prevention report, 38% adult citizen of US are obese which also includes 17% of teenagers.
Last year, Aspire Bariatrics received a loan facility of $12 million from Hercules Technology Growth Capital for the development of the stomach pump. The pricing of the device which is in the Europe market is still not revealed and the implantation charges may vary based on the centers.
“Patients require frequent monitoring by a health care provider to shorten the tube as they lose weight and abdominal girth, so that the disk remains flush against their skin. Frequent medical visits are also necessary to monitor device use and weight loss and to provide counseling on lifestyle therapies,” the FDA emphasized.
Featured Image: Snapshot of AspireAssist Aspiration Therapy System (credit: Aspire Bariatrics).